Akums reports Q1 FY26 total income of Rs. 1,051 crore with 2.4% growth, 19% YoY adjusted EBITDA growth
Akums Drugs and Pharmaceuticals, a contract development and manufacturing organization (CDMO), in its financial results for Q1 reported total income of Rs. 1,051 crore compared to Rs. 1,026 crore in the corresponding year indicating a 2.4 per cent growth …